Regístrese
¿Aún no está registrado?
Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta
Buscar en
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
Toda la web
Inicio Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)
ISSN: 2253-8089

The Revista Española de Medicina Nuclear e Imagen Molecular (Spanish Journal of Nuclear Medicine and Molecular Imaging), was founded in 1982, and is the official journal of the Spanish Society of Nuclear Medicine and Molecular Imaging, which has more than 700 members.
The Journal, which publishes 6 regular issues per year, has the promotion of research and continuing education in all fields of Nuclear Medicine as its main aim. For this, its principal sections are Originals, Clinical Notes, Images of Interest, and Special Collaboration articles. The works may be submitted in Spanish or English and are subjected to a peer review process.
In 2009, it became the leading Spanish journal in the field of Medical Imaging on having an Impact Factor , awarded by the Journal Citation Reports.

See more

Indexed in:

Science Citation Index Expander, Medline, IME, Bibliomed, EMBASE/Excerpta Medica, Healthstar, Cancerlit, Toxine, Inside Conferences, Scopus

See more

Follow us:

2017
1.202
Impact Factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.

© Clarivate Analytics, Journal Citation Reports 2017 2017

Impact Factor 2017
1.202
CiteScore 2017

CiteScore measures average citations received per document published. Read more

CiteScore 2017
0.59

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR
0.278

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP
0.363
See more
Hide
Issue
Vol. 38. Num. 2.
Pages 69-136 (March - April 2019)
Editorial
General Data Protection Regulation. What is new?
M. Milà, F. Abellán
Rev Esp Med Nucl Imagen Mol.2019;38:69-71
Original articles
Comparison of four methods for quantitative assessment of 99mTc-MDP SPECT in patients with suspected condylar hyperplasia
Diego F. López Buitrago, Juan M. Muñoz Acosta, Rodrigo A. Cárdenas-Perilla
Rev Esp Med Nucl Imagen Mol.2019;38:72-9
Tumor characteristics of lung cancer in predicting axillary lymph node metastases
Funda Üstün, Burcu Tokuc, Ebru Tastekin, Gülay Durmuş Altun
Rev Esp Med Nucl Imagen Mol.2019;38:80-6
Clinical and prognostic value of 18F-FDG PET/CT in recurrent endometrial carcinoma
Domenico Albano, Valentina Zizioli, Franco Odicino, Raffaele Giubbini, Francesco Bertagna
Rev Esp Med Nucl Imagen Mol.2019;38:87-93
68Ga-DOTATOC PET/CT in the localization of metastatic extra-adrenal paraganglioma and pheochromocytoma compared with 18F-DOPA PET/CT
Alexander Stephan Kroiss, Christian Uprimny, Barry Lynn Shulkin, Leonhard Gruber, Andreas Frech, Thomas Jazbec, Pierre Pascal Girod, Christoph Url, Claudius Thomé, Herbert Riechelmann, Georg Mathias Sprinzl, Gustav Fraedrich, Irene Johanna Virgolini
Rev Esp Med Nucl Imagen Mol.2019;38:94-9
Special collaboration
Relevance of radium-223 in hospital clinical practice from a medical oncologist point of view
R. Lozano, E. Almagro, E. Castro
Rev Esp Med Nucl Imagen Mol.2019;38:106-11
Letter to the editor
Quantitative assessment is essential for interpreting lymphoscintigraphy: Response to Ramin Sadeghi's letter to the editor
I. Forner-Cordero, P. Oliván-Sasot, C. Ruiz-Llorca, J. Muñoz-Langa
Rev Esp Med Nucl Imagen Mol.2019;38:112-3
Interesting images
False-positive 131I uptake secondary to nabothian cyst
F.J. García-Gómez, T. Cambil-Molina, J. Jiménez Gallardo, T. Martín-Hernández, J. Castro-Montaño
Rev Esp Med Nucl Imagen Mol.2019;38:114-5
99mTc-MAG3 SPECT/CT in a case of urolithiasis
M.A. Ochoa-Figueroa, A. Davidsson, V. Sánchez-Rodríguez
Rev Esp Med Nucl Imagen Mol.2019;38:116-7
Detection of hyperfunctioning parathyroid tissue by PET/CT with 18F-Fluorocholine
D. Villasboas-Rosciolesi, A. García-Burillo, O. González-López, E. Caubet-Busquet, J. Castell-Conesa
Rev Esp Med Nucl Imagen Mol.2019;38:118-20
Digital PET/CT vs. analog PET/CT in a parathyroid gland study with 18F-Fluorocholine
D.A. López-Mora, M. Estorch, F. Fuentes-Ocampo, J.I. Pérez García, A. Moral, I. Carrio
Rev Esp Med Nucl Imagen Mol.2019;38:121-2
Continuing education
Update of the role of Nuclear Medicine techniques in the pre-surgical localization of primary hyperparathyroidism
P. García-Talavera San Miguel, F. Gómez-Caminero López, J.G. Villanueva Curto, M.P. Tamayo Alonso, M.E. Martín Gómez
Rev Esp Med Nucl Imagen Mol.2019;38:123-35
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.